NEWS 01.28.2026 Mesoblast Healthcare Developments Across ASX 200 Biotechnology Segment – Kalkine Media
NEWS 01.28.2026 Mesoblast (ASX:MSB) Valuation Check As Ryoncil Access And Early Commercial Outcomes Progress – simplywall.st
NEWS 01.28.2026 Creative Biolabs Strengthens iPSC Research with a Wide Range of Advanced Solutions – FinancialContent
NEWS 01.28.2026 T&R Biofab jumps as Korea unveils block-based 3D artificial organ tech – CHOSUNBIZ – Chosunbiz
